NMI Holdings, Inc. (NMIH)
NASDAQ: NMIH · Real-Time Price · USD
37.20
-0.12 (-0.32%)
At close: Aug 1, 2025, 4:00 PM
37.19
-0.01 (-0.03%)
After-hours: Aug 1, 2025, 4:10 PM EDT
CTI BioPharma Analyst Ratings
Total Analysts
7
Consensus Rating
Buy
Price Target
$43.00
Upside
+15.59%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $41 → $44 | Buy | Maintains | $41 → $44 | +18.28% | Jul 11, 2025 |
| Barclays | Barclays | Hold Maintains $41 → $42 | Hold | Maintains | $41 → $42 | +12.90% | Jul 8, 2025 |
| Keefe, Bruyette & Woods | Keefe, Bruyette & Woods | Buy → Hold Downgrades $42 → $43 | Buy → Hold | Downgrades | $42 → $43 | +15.59% | Jul 7, 2025 |
| Compass Point | Compass Point | Strong Buy Maintains $34 → $37 | Strong Buy | Maintains | $34 → $37 | -0.54% | May 23, 2025 |
| Keefe, Bruyette & Woods | Keefe, Bruyette & Woods | Buy Maintains $43 → $42 | Buy | Maintains | $43 → $42 | +12.90% | Apr 8, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $42 → $41 | Buy | Maintains | $42 → $41 | +10.22% | Apr 8, 2025 |
| Keefe, Bruyette & Woods | Keefe, Bruyette & Woods | Hold → Buy Upgrades $43 | Hold → Buy | Upgrades | $43 | +15.59% | Feb 24, 2025 |
| UBS | UBS | Hold Maintains $42 → $41 | Hold | Maintains | $42 → $41 | +10.22% | Feb 19, 2025 |
| UBS | UBS | Hold Maintains $40 → $42 | Hold | Maintains | $40 → $42 | +12.90% | Jan 10, 2025 |
| Keefe, Bruyette & Woods | Keefe, Bruyette & Woods | Hold Maintains $44 → $43 | Hold | Maintains | $44 → $43 | +15.59% | Jan 8, 2025 |
| Barclays | Barclays | Buy → Hold Downgrades $48 → $41 | Buy → Hold | Downgrades | $48 → $41 | +10.22% | Jan 6, 2025 |
| Keefe, Bruyette & Woods | Keefe, Bruyette & Woods | Hold Maintains $43 → $44 | Hold | Maintains | $43 → $44 | +18.28% | Dec 10, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $46 → $41 | Buy | Maintains | $46 → $41 | +10.22% | Dec 9, 2024 |
| UBS | UBS | Hold Maintains $41 → $40 | Hold | Maintains | $41 → $40 | +7.53% | Nov 12, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $48 → $47 | Buy | Maintains | $48 → $47 | +26.34% | Nov 7, 2024 |
| Barclays | Barclays | Buy Maintains $43 → $48 | Buy | Maintains | $43 → $48 | +29.03% | Oct 8, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.